BIG PHARMA WATCH: BIG PHARMA DELAYS NEW DRUGS THAT COULD HELP PATIENTS TO BOOST PROFITS
Jan 8, 2024
Report Finds Several Brand Name Drug Companies Waiting to Introduce New… Read More
© 2025 CSRXP- All Rights Reserved
Big Pharma Watch
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST EIGHT BRAND NAME DRUGS COST U.S. $1.2 BILLION IN 2022
Dec 11, 2023
New Analysis Showcases How Big Pharma Raises Prices on Blockbuster Products… Read More
BIG PHARMA WATCH: PHARMA PATENTS INVALIDATED MORE THAN ANY OTHER INDUSTRY FOR MISREPRESENTED OR OMITTED INFORMATION
Nov 17, 2023
Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug… Read More
BIG PHARMA WATCH: BIG PHARMA HIKED PRICES ON MORE THAN 100 MEDICATIONS ABOVE THE RATE OF INFLATION THIS SUMMER
Nov 2, 2023
New Analysis Finds Drug Companies Continue to Price-Gouge American Patients,… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK AND BRISTOL MYERS SQUIBB
Oct 27, 2023
More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following… Read More
BIG PHARMA WATCH: ONCOLOGISTS WHO RECEIVED BIG PHARMA KICKBACKS WERE MORE LIKELY TO PRESCRIBE HIGHER PRICED AND LESS EFFECTIVE DRUGS
Oct 27, 2023
Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and… Read More
BIG PHARMA WATCH: PFIZER TO RAISE PRICE ON COVID-19 TREATMENT NEARLY 300 PERCENT
Oct 19, 2023
Big Pharma Giant Increases Paxlovid Price Weeks After Making Price Hike on… Read More
BIG PHARMA WATCH: KICKBACKS INCREASED SPENDING ON HIGH PRICED AGE-RELATED MACULAR DEGENERATION DRUGS BY $642.8 MILLION OVER SIX YEARS
Oct 3, 2023
Eye Doctors Who Accepted Big Pharma Payments Were More Likely to Prescribe… Read More
Big Pharma Watch: Study Finds Patent Thickets on Just Four Drugs Extended Monopolies By a Combined 25 Years
Sep 20, 2023
I-MAK Analysis Reveals Patent Abuse on Four Blockbuster Medications Generated… Read More
BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET
Aug 17, 2023
AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226… Read More
BIG PHARMA WATCH: COLOSSAL $81.9 BILLION IN 2022 EARNINGS FOR LARGEST DRUG MAKERS FUELED HUGE PROFITS
Jul 25, 2023
Top Five Drug Makers By U.S. Market Cap Plowed Soaring Earnings Into Stock… Read More
BIG PHARMA WATCH: DRUG MAKER’S PRODUCT-HOPPING SCHEME BLOCKED ACCESS TO SAFER HIV MEDICATIONS TO JUICE PROFITS
Jul 24, 2023
The New York Times Exposes How Gilead Devised Egregious Patent Strategy to… Read More